Cephalon
Teva Pharmaceutical Industries said Monday it planned to buy Cephalon Inc.
for $6.8 billion US in a move that beats out a hostile bid from Toronto-based Valeant Pharmaceuticals
Source: http://www.cbc.ca/news/business/story/2011/05/02/teva-cephalon-valeant.html
Created by: Fran | Created at: 08:05 PM





Loading...